UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 20, 2014
EnzymeBioSystems
(Exact name of registrant as specified in its charter)
Commission File Number: 000-53854
| Nevada | 27-0464302 | |
| (State or other jurisdiction of | (IRS Employer | |
| incorporation) | Identification No.) |
| 7575 W. Washington Ave., #127, Las Vegas, NV | 89128 | |
| (Address of principal executive offices) | (Zip Code) |
(702) 631-4251
(Registrant’s telephone number, including area code)
16773 W Park Drive, Chagrin Falls, Ohio 44023
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
-1-
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On October 20, 2014, the Board of Directors of EnzymeBioSystems ("the Company" or the "Registrant") accepted the resignation of Mr. Anushavan Yeranosyan, in his position as Chief Accounting Officer and Director of the Corporation. Mr. Yeranosyan desires to pursue other interests and does not have any disagreements with the Corporation on any matter relating to its operations, policies or practices.
On October 20, 2014, the Board of Directors of EnzymeBioSystems, nominated and unanimously approved Gary Rojewski and Ed Zimmerman III as Directors of the Company. Mr. Rojewski is currently CEO of the Company. The Board also unanimously appointed Mr. Edward Zimmerman III as Chief Financial Officer, Treasurer and Corporate Secretary of the Company. The newly appointed officer serves at the pleasure of the Board, he will hold his position(s) until his successor(s) shall be appointed and shall qualify or until the earlier of his death, resignation or removal in the manner provided for in the By-laws of the Corporation.
CURRENT DIRECTORS AND OFFICERS
The names, ages and positions of the Company's director and executive officer are as follows:
| Name | Age | Position & Offices Held |
| Gary Rojeswki | 61 | Director/CEO |
| Edward Zimmerman III | 36 | Director, CFO/Treasurer/Corporate Secretary |
| Ashot Martirosyan | 62 | Director/Chief Scientific Officer |
Biographies of the Management Team of EzymeBioSystems
Gary Rojewski, Chief Executive Officer/Director
Gary Rojewski has 29-years experience in the pharmaceutical industry. During that time he has worked for Procter & Gamble Pharmaceuticals, Warner Chilcott Pharmaceuticals and most recently Actavis. Throughout his pharmaceutical career he has been responsible for commercializing pharmaceutical products.
2014 - Present Chief Executive Officer of EnzymeBioSystems
2013 – 2014 Account Executive Managed Markets Actavis, Inc., Parsippany, NJ
2009 – 2013 Account Executive Managed Markets Warner Chilcott Pharmaceuticals, Rockaway, NJ
1984 – 2009 Sales Representative, District Manager, Account Executive Procter & Gamble Pharmaceuticals, Cincinnati, OH
1976 – 1984 Sales Representative at W. Berman Company, Ohio
1975 – 1976 Admissions Recruiter at Davis Junior College/I.T.T. Technical College.
Education
1971 – 1975
University of Findlay
Findlay, OH
B.A. Communications
-2-
Edward Zimmerman III, Director, CFO, Treasurer and Secretary
Edward C. Zimmerman III brings to EnzymeBioSystems over thirteen years of experience working in the financial industry. Mr. Zimmerman has experience as a former CEO of three reporting companies, and also has worked with many other Company providing bookkeeping services, as well as assisting their respective management in the presentation of GAAP (Generally Accepted Accounting Principles) standard financial statements for use in quarterly and annual reports. Additionally, Mr. Zimmerman brings his experience as an EDGAR filer for the past thirteen years.
Edward C. Zimmerman III - Work Background
American Riding Tours, Inc.
Las Vegas, Nevada
President and Tour Director
February 2013-Present
Law Offices of Thomas C. Cook, Ltd.
Las Vegas, Nevada
Law Clerk
March 2002-Present
National Filing Agents, Inc.
Las Vegas, Nevada
President. Company providing EDGAR file services
December 2002-October 2007
EZ Travel, Inc.
Las Vegas, Nevada
President and Travel Counselor
December 2001-March 2003
Ambassador Travel
Las Vegas, NV
Manager and Travel Counselor
1998 - 2002
Education:
Bonanza High School
Las Vegas, Nevada
Diploma, 1996
Heritage College
Las Vegas, Nevada
Diploma Travel & Tourism, 1998
-3-
Ashot Martirosyan, Chief Scientific Officer and Director
Mr. Martirosyan was the head of the "Anti-Biotics and Enzyme Inhibitors Laboratory" of "Institute of Organic Chemistry" in Yerevan, Armenia until November 2008. He moved to USA November 2008 and started preparing his research results and scientific materials for publications.
Mar. 2009 –Present
President and Director of EnzymeBioSystems.
1992 – 2008
Institute of Fine Organic Chemistry,
National Academy of Sciences, Republic of Armenia
Head of Antibiotics Laboratory
1984 – 1992
Institute of Fine Organic Chemistry,
National Academy of Sciences, Republic of Armenia
Senior Researcher
1976 – 1984
Institute of Fine Organic Chemistry,
National Academy of Sciences, Republic of Armenia
Antibiotics Laboratory Researcher
1974 – 1976
Optical-Mechanical Corporation – "Astro"
Head of Chemical Laboratory
Republic of Armenia
Education:
1980 – 1984
Yerevan State University
Ph.D. degree, Candidate of Chemical Sciences: Organic Chemistry
1969 – 1974
Moscow Chemical and Technological Institute of D.I. Mendeleev
Department of Organic Chemistry, Chemical Technology
-4-
Item 8.01 - Other Events.
The Registrant has changed its principal executive offices to: 7575 W. Washington Ave., #127, Las Vegas, NV 89128; from: 16773 W Park Drive, Chagrin Falls, Ohio 44023.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
EnzymeBioSystems Registrant | |
| Date: October 23, 2014 | /s/ Edward Zimmerman III |
|
Name: Edward Zimmerman III Title: Corporate Secretary
|
-5-